We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HBB icon
2526
Hamilton Beach Brands
HBB
$300M
– –
-1,500
Closed -$24
HEZU icon
2527
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$568M
– –
-3,500
Closed -$108
HOFT icon
2528
Hooker Furnishings Corp
HOFT
$149M
– –
-11
Closed –
HY icon
2529
Hyster-Yale Materials Handling
HY
$596M
– –
-1,000
Closed -$54
IBKR icon
2530
Interactive Brokers
IBKR
$41.1B
– –
-272
Closed -$3
IDOG icon
2531
ALPS International Sector Dividend Dogs ETF
IDOG
$538M
– –
-20
Closed –
IDV icon
2532
iShares International Select Dividend ETF
IDV
$8.24B
– –
-685
Closed -$21
IEUS icon
2533
iShares MSCI Europe Small-Cap ETF
IEUS
$177M
– –
-30
Closed -$1
IGE icon
2534
iShares North American Natural Resources ETF
IGE
$735M
$0 ﹤0.01%
+14
New +$408
IHT
2535
InnSuites Hospitality Trust
IHT
$16.1M
$0 ﹤0.01%
100
– –
ITIC
2536
Investors Title Co
ITIC
$537M
$0 ﹤0.01%
1
– –
IXUS icon
2537
iShares Core MSCI Total International Stock ETF
IXUS
$57.7B
– –
-514
Closed -$29
JKS
2538
JinkoSolar
JKS
$799M
$0 ﹤0.01%
34
– –
KAI icon
2539
Kadant
KAI
$3.69B
– –
-2,345
Closed -$205
KGC icon
2540
Kinross Gold
KGC
$28.6B
$0 ﹤0.01%
44
-3,586
-99% -$16.2K
KOD icon
2541
Kodiak Sciences
KOD
$2.62B
– –
-550
Closed -$7
KOPN icon
2542
Kopin
KOPN
$687M
$0 ﹤0.01%
1,000
– –
LCTX icon
2543
Lineage Cell Therapeutics
LCTX
$257M
$0 ﹤0.01%
2
– –
LE icon
2544
Lands' End
LE
$375M
$0 ﹤0.01%
8
-92
-92% -$1.2K
LILA icon
2545
Liberty Latin America Class A
LILA
$1.57B
$0 ﹤0.01%
45
– –
LIVN icon
2546
LivaNova
LIVN
$4.43B
$0 ﹤0.01%
12
– –
LMNR icon
2547
Limoneira
LMNR
$242M
$0 ﹤0.01%
48
-61
-56% -$1.17K
MDXG icon
2548
MiMedx Group
MDXG
$635M
$0 ﹤0.01%
41
– –
MERC icon
2549
Mercer International
MERC
$44.7M
– –
-624
Closed -$7
KG
2550
Kestrel Group
KG
$70.1M
$0 ﹤0.01%
13
– –
100 101
102
103 104

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.